New research from GovGrant, R&D and IP specialist, reveals that 86% of UK SMEs in health-related sectors think innovation is important for their recovery from COVID-19. Despite this, almost half (47%) - healthcare, medtech and pharma - say the cost is the main barrier for them when it comes to pursuing innovative activity. The news […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!